MOORE CAPITAL MANAGEMENT, LP

Position in FLGT — Fulgent Genetics, Inc.

CIK 1448574 NEW YORK, NY

Position in FLGT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$733,371

New position

Shares Held

46,124

first reported quarter

Ownership

0.162%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MOORE CAPITAL MANAGEMENT, LP holds $33,834,798 across 8 Diagnostics & Research names. FLGT ranks #8 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ICLR	Icon PLC	147,208	$16,290,037
2	CRL	Charles River Laboratories International, Inc.	43,234	$7,457,865
3	SHC	Sotera Health Co	252,441	$3,620,003
4	VCYT	Veracyte, Inc.	79,760	$2,569,069
5	IQV	Iqvia Holdings Inc.	8,097	$1,380,862
6	MYGN	Myriad Genetics Inc	218,398	$982,791
7	QGEN	Qiagen N.V.	20,000	$800,800
8	FLGT	Fulgent Genetics, Inc. This page	46,124	$733,371

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$733,371	46,124	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.